SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001062993-23-019598
Filing Date
2023-10-20
Accepted
2023-10-20 14:56:49
Documents
10
Period of Report
2023-11-09

Document Format Files

Seq Description Document Type Size
1 FORM 6-K form6k.htm 6-K 5571
2 EXHIBIT 99.1 exhibit99-1.htm EX-99.1 325575
3 EXHIBIT 99.2 exhibit99-2.htm EX-99.2 4874
4 EXHIBIT 99.3 exhibit99-3.htm EX-99.3 4756
5 EXHIBIT 99.4 exhibit99-4.htm EX-99.4 719
6 GRAPHIC exhibit99-1x001.jpg GRAPHIC 22152
7 GRAPHIC exhibit99-3xu001.jpg GRAPHIC 2839
8 GRAPHIC exhibit99-3xu002.jpg GRAPHIC 18057
9 GRAPHIC exhibit99-4xu001.jpg GRAPHIC 189495
10 GRAPHIC exhibit99-4xu002.jpg GRAPHIC 143739
  Complete submission text file 0001062993-23-019598.txt   861425
Mailing Address 880 - 580 HORNBY STREET VANCOUVER A1 V6C3B6
Business Address 880 - 580 HORNBY STREET VANCOUVER A1 V6C3B6 6048060626
ImmunoPrecise Antibodies Ltd. (Filer) CIK: 0001715925 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0430
Type: 6-K | Act: 34 | File No.: 001-39530 | Film No.: 231336954
SIC: 2834 Pharmaceutical Preparations